Syngenta: Enogen premiums to growers top $100 million in 2018

By Syngenta | February 28, 2018

Since its introduction, Enogen corn enzyme technology has provided corn growers the opportunity to be enzyme suppliers for participating ethanol plants and earn a per-bushel premium. Syngenta today announced that premiums-to-date paid to Enogen corn growers are expected to surpass $100 million during 2018.

Nearly 40 percent of U.S. corn goes toward ethanol production. According to Chris Tingle, head of commercial operations for Enogen at Syngenta, providing alpha amylase enzyme to ethanol plants as Enogen grain is helping corn growers maximize return on investment for their ethanol acres. He added that this unique business model supports rural America by keeping enzyme dollars local and helping ethanol plants be more successful.

“With Enogen, ethanol producers can redirect the money they previously used to buy liquid alpha amylase to local farmers instead, in the form of an up to 40-cent-per-bushel premium,” Tingle said. “This is especially significant given current commodity prices and, as these premium dollars are circulated locally, promotes the growth and stability of rural communities through a homegrown fuel that is helping to make America more energy independent.”

Syngenta is currently contracting with more than 1,700 corn growers and has marketing agreements with 31 ethanol plants across 12 states. 2018 ethanol production with Enogen corn is expected to be over 2.5 billion gallons.

“Ethanol has become an important success story,” Tingle added, “and is helping America reduce its dependence on foreign oil, lowering prices at the pump, improving the environment with lower emissions, and growing the economy with jobs that can’t be outsourced. Syngenta is proud to partner with corn growers and the ethanol industry to help provide consumers with the choice to purchase a superior, higher octane fuel and pay less.”

For more information about Enogen corn hybrids, contact a Golden Harvest® Seed Advisor or NK® retailer, or visit